ĀÜĄņĀŅĀ×

Martin Dieck is a seasoned executive with extensive experience in medical technology and investment. Currently serving as Chairman at Synchron, Dieck is instrumental in developing the STENTRODEā„¢, the world's first endovascular brain-machine interface. Other leadership roles include Managing Member at Neuro Technology Investors, LLC, and General Partner at Neurotechnology Partners Fund, LLC. Dieck also holds directorships at Basecamp Vascular and Hyperion Surgical, along with a founding position at Borvo Medical, Inc. Since 2019, Dieck has directed the Turtle Conservancy, promoting environmental conservation. Dieck's academic credentials include an MBA from the University of California, Berkeley, and a BA in Biology from Willamette University.